THC Farmaceuticals, Inc. (CBDG)
OTCMKTS · Delayed Price · Currency is USD
0.0102
0.00 (0.00%)
Jul 15, 2025, 4:00 PM EDT

THC Farmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2014FY 2013FY 2012FY 2011FY 20102009
Period Ending
Jul '25 Sep '14 Sep '13 Sep '12 Sep '11 Sep '10 2009
010----
Upgrade
Enterprise Value
-10----
Upgrade
Last Close Price
0.011.10----
Upgrade
PS Ratio
9.99518.27----
Upgrade
PB Ratio
0.18-205.45----
Upgrade
EV/Sales Ratio
-522.19----
Upgrade
Debt / Equity Ratio
0.68-1.62-3.396.330.370.54
Upgrade
Debt / EBITDA Ratio
-----15.94
Upgrade
Debt / FCF Ratio
----0.8313.12
Upgrade
Asset Turnover
0.020.390.430.520.38-
Upgrade
Quick Ratio
1.980.400.720.572.416.65
Upgrade
Current Ratio
1.980.400.720.572.416.65
Upgrade
Return on Equity (ROE)
-14.87%---150.55%-46.96%-
Upgrade
Return on Assets (ROA)
-4.96%-31.00%-24.38%-25.02%-16.32%-
Upgrade
Return on Capital (ROIC)
-5.04%-42.22%-27.45%-26.50%-16.70%-
Upgrade
Return on Capital Employed (ROCE)
-----0.50%
Upgrade
Earnings Yield
-39.19%-0.31%----
Upgrade
FCF Yield
--0.19%----
Upgrade
Buyback Yield / Dilution
-50.42%----69.35%-2.08%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.